

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 8.63152229 |
| 2 | regulation of apoptotic cell clearance (GO:2000425) | 7.01963379 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.89725274 |
| 4 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.37430540 |
| 5 | regulation of platelet aggregation (GO:0090330) | 6.32554321 |
| 6 | protein neddylation (GO:0045116) | 5.95166764 |
| 7 | blood coagulation, intrinsic pathway (GO:0007597) | 5.68218524 |
| 8 | platelet aggregation (GO:0070527) | 5.49606026 |
| 9 | complement activation, alternative pathway (GO:0006957) | 5.43531658 |
| 10 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.15902943 |
| 11 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 5.15251410 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.12266576 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.12266576 |
| 14 | mannose metabolic process (GO:0006013) | 5.08404379 |
| 15 | germinal center formation (GO:0002467) | 5.07791650 |
| 16 | * regulation of platelet activation (GO:0010543) | 5.06418967 |
| 17 | lipoxygenase pathway (GO:0019372) | 5.00478895 |
| 18 | negative regulation of platelet activation (GO:0010544) | 4.96470833 |
| 19 | apoptotic cell clearance (GO:0043277) | 4.91535000 |
| 20 | lymph vessel development (GO:0001945) | 4.84490404 |
| 21 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.70700298 |
| 22 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.62065601 |
| 23 | transcytosis (GO:0045056) | 4.56010104 |
| 24 | positive regulation of mast cell activation (GO:0033005) | 4.55198898 |
| 25 | endothelial cell chemotaxis (GO:0035767) | 4.52321344 |
| 26 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.51336427 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.50917151 |
| 28 | * regulation of integrin activation (GO:0033623) | 4.45652566 |
| 29 | adenosine receptor signaling pathway (GO:0001973) | 4.45006022 |
| 30 | definitive hemopoiesis (GO:0060216) | 4.44343554 |
| 31 | detection of molecule of bacterial origin (GO:0032490) | 4.35579023 |
| 32 | * leukocyte tethering or rolling (GO:0050901) | 4.32729352 |
| 33 | neutrophil activation (GO:0042119) | 4.30564517 |
| 34 | negative regulation of granulocyte differentiation (GO:0030853) | 4.27100102 |
| 35 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.25016784 |
| 36 | cellular extravasation (GO:0045123) | 4.21718162 |
| 37 | response to interferon-beta (GO:0035456) | 4.17858926 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.09305309 |
| 39 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.09221225 |
| 40 | negative regulation of norepinephrine secretion (GO:0010700) | 4.07617289 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.07401288 |
| 42 | opsonization (GO:0008228) | 4.06633425 |
| 43 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.06119010 |
| 44 | protein kinase C signaling (GO:0070528) | 4.05199559 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.02066229 |
| 46 | homotypic cell-cell adhesion (GO:0034109) | 3.89049247 |
| 47 | * platelet degranulation (GO:0002576) | 3.83319511 |
| 48 | citrulline biosynthetic process (GO:0019240) | 3.81783901 |
| 49 | negative regulation of heart rate (GO:0010459) | 3.76943984 |
| 50 | response to interferon-alpha (GO:0035455) | 3.74780628 |
| 51 | granulocyte activation (GO:0036230) | 3.73622469 |
| 52 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.73414785 |
| 53 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.73274913 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.73274913 |
| 55 | regulation of lipoprotein metabolic process (GO:0050746) | 3.72295646 |
| 56 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.70826835 |
| 57 | megakaryocyte development (GO:0035855) | 3.70805066 |
| 58 | positive regulation of T cell chemotaxis (GO:0010820) | 3.70286916 |
| 59 | regulation of T cell chemotaxis (GO:0010819) | 3.70286916 |
| 60 | * platelet activation (GO:0030168) | 3.68057732 |
| 61 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.67981409 |
| 62 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.64622853 |
| 63 | regulation of humoral immune response (GO:0002920) | 3.62720846 |
| 64 | platelet formation (GO:0030220) | 3.55068388 |
| 65 | secretory granule organization (GO:0033363) | 3.53210110 |
| 66 | blood vessel maturation (GO:0001955) | 3.51409645 |
| 67 | positive regulation of receptor recycling (GO:0001921) | 3.51162293 |
| 68 | regulation of complement activation (GO:0030449) | 3.49367168 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.48381866 |
| 70 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.47732121 |
| 71 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.47033285 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.45607600 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45484933 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.44304804 |
| 75 | positive regulation of macrophage differentiation (GO:0045651) | 3.44013507 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41567636 |
| 77 | negative regulation of endothelial cell migration (GO:0010596) | 3.39673991 |
| 78 | angiogenesis involved in wound healing (GO:0060055) | 3.39326594 |
| 79 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.38091145 |
| 80 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.36498937 |
| 81 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36185668 |
| 82 | complement activation (GO:0006956) | 3.35487802 |
| 83 | cyclooxygenase pathway (GO:0019371) | 3.33698035 |
| 84 | cellular response to interleukin-6 (GO:0071354) | 3.33008509 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.32444183 |
| 86 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.32386158 |
| 87 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.32227258 |
| 88 | lymph node development (GO:0048535) | 3.31183283 |
| 89 | positive regulation of Rap GTPase activity (GO:0032854) | 3.31127900 |
| 90 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.29481147 |
| 91 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.29152740 |
| 92 | regulation of macrophage chemotaxis (GO:0010758) | 3.28795789 |
| 93 | ribosomal small subunit assembly (GO:0000028) | 3.28456944 |
| 94 | positive regulation of granulocyte differentiation (GO:0030854) | 3.28379508 |
| 95 | extracellular fibril organization (GO:0043206) | 3.27564769 |
| 96 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.27469712 |
| 97 | regulation of protein activation cascade (GO:2000257) | 3.26158420 |
| 98 | negative regulation of appetite (GO:0032099) | 3.25847624 |
| 99 | negative regulation of response to food (GO:0032096) | 3.25847624 |
| 100 | autophagic vacuole fusion (GO:0000046) | 3.23498237 |
| 101 | protein activation cascade (GO:0072376) | 3.20990645 |
| 102 | regulation of endothelial cell differentiation (GO:0045601) | 3.20105985 |
| 103 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.19329735 |
| 104 | regulation of mast cell activation (GO:0033003) | 3.19144256 |
| 105 | regulation of cellular extravasation (GO:0002691) | 3.18458887 |
| 106 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18421316 |
| 107 | negative regulation of bone mineralization (GO:0030502) | 3.17887577 |
| 108 | relaxation of smooth muscle (GO:0044557) | 3.16511246 |
| 109 | negative regulation of T cell apoptotic process (GO:0070233) | 3.15062186 |
| 110 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.13686219 |
| 111 | adhesion of symbiont to host (GO:0044406) | 3.13528962 |
| 112 | regulation of mast cell degranulation (GO:0043304) | 3.11777916 |
| 113 | negative regulation of macrophage differentiation (GO:0045650) | 3.09829241 |
| 114 | chronic inflammatory response (GO:0002544) | 3.09693904 |
| 115 | endothelial tube morphogenesis (GO:0061154) | 3.08901520 |
| 116 | morphogenesis of an endothelium (GO:0003159) | 3.08901520 |
| 117 | positive regulation of mast cell degranulation (GO:0043306) | 3.08226314 |
| 118 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.08226314 |
| 119 | purinergic receptor signaling pathway (GO:0035587) | 3.07843071 |
| 120 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.07812909 |
| 121 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.07490923 |
| 122 | positive regulation of respiratory burst (GO:0060267) | 3.07279341 |
| 123 | platelet dense granule organization (GO:0060155) | 3.07125545 |
| 124 | phagocytosis, engulfment (GO:0006911) | 3.04941688 |
| 125 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04493802 |
| 126 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.03548788 |
| 127 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.03182436 |
| 128 | regulation of female receptivity (GO:0045924) | 3.01544351 |
| 129 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00872073 |
| 130 | polyamine biosynthetic process (GO:0006596) | 3.00684192 |
| 131 | regulation of T cell migration (GO:2000404) | 3.00674025 |
| 132 | response to type I interferon (GO:0034340) | 3.00637509 |
| 133 | cytokine production involved in immune response (GO:0002367) | 2.97984730 |
| 134 | positive regulation of B cell differentiation (GO:0045579) | 2.95211738 |
| 135 | ovulation from ovarian follicle (GO:0001542) | 2.93205380 |
| 136 | negative regulation of viral entry into host cell (GO:0046597) | 2.92961515 |
| 137 | type I interferon signaling pathway (GO:0060337) | 2.92543469 |
| 138 | cellular response to type I interferon (GO:0071357) | 2.92543469 |
| 139 | regulation of phagocytosis (GO:0050764) | 2.92139304 |
| 140 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.92107125 |
| 141 | regulation of memory T cell differentiation (GO:0043380) | 2.92084637 |
| 142 | fibril organization (GO:0097435) | 2.90271356 |
| 143 | negative regulation of protein localization to cell surface (GO:2000009) | 2.88958928 |
| 144 | detection of biotic stimulus (GO:0009595) | 2.88445780 |
| 145 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.87923602 |
| 146 | glomerular filtration (GO:0003094) | 2.87833055 |
| 147 | peptide catabolic process (GO:0043171) | 2.87676091 |
| 148 | regulation of cholesterol storage (GO:0010885) | 2.86875554 |
| 149 | myeloid cell development (GO:0061515) | 2.85865044 |
| 150 | negative regulation of stress fiber assembly (GO:0051497) | 2.85214576 |
| 151 | negative regulation of heart contraction (GO:0045822) | 2.83570046 |
| 152 | positive regulation of antigen processing and presentation (GO:0002579) | 2.83501178 |
| 153 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.82574175 |
| 154 | leukocyte degranulation (GO:0043299) | 2.82368839 |
| 155 | establishment of endothelial barrier (GO:0061028) | 2.81770015 |
| 156 | * regulation of blood coagulation (GO:0030193) | 2.80458376 |
| 157 | * regulation of hemostasis (GO:1900046) | 2.80458376 |
| 158 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.80112741 |
| 159 | endothelial cell morphogenesis (GO:0001886) | 2.80080902 |
| 160 | mesodermal cell differentiation (GO:0048333) | 2.79694659 |
| 161 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.76814359 |
| 162 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.76773260 |
| 163 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.76614013 |
| 164 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76603954 |
| 165 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.76161541 |
| 166 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75718204 |
| 167 | termination of signal transduction (GO:0023021) | 2.75182107 |
| 168 | negative regulation of biomineral tissue development (GO:0070168) | 2.74392576 |
| 169 | negative regulation of interleukin-17 production (GO:0032700) | 2.73739297 |
| 170 | * leukocyte cell-cell adhesion (GO:0007159) | 2.73546256 |
| 171 | cGMP-mediated signaling (GO:0019934) | 2.73143180 |
| 172 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.72178074 |
| 173 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71343905 |
| 174 | regulation of receptor recycling (GO:0001919) | 2.70591547 |
| 175 | leukotriene metabolic process (GO:0006691) | 2.69121629 |
| 176 | endothelium development (GO:0003158) | 2.69110559 |
| 177 | cell adhesion mediated by integrin (GO:0033627) | 2.68525093 |
| 178 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.67152330 |
| 179 | organelle membrane fusion (GO:0090174) | 2.67056790 |
| 180 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.67029969 |
| 181 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66489091 |
| 182 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66489091 |
| 183 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.66275426 |
| 184 | response to protozoan (GO:0001562) | 2.66269104 |
| 185 | lymphangiogenesis (GO:0001946) | 2.65542861 |
| 186 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64637849 |
| 187 | * positive regulation of hemostasis (GO:1900048) | 2.64502252 |
| 188 | * positive regulation of blood coagulation (GO:0030194) | 2.64502252 |
| 189 | regulation of antigen processing and presentation (GO:0002577) | 2.64384392 |
| 190 | icosanoid biosynthetic process (GO:0046456) | 2.63524645 |
| 191 | fatty acid derivative biosynthetic process (GO:1901570) | 2.63524645 |
| 192 | positive regulation of receptor internalization (GO:0002092) | 2.61285493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.89781917 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.36817410 |
| 3 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.92476915 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86534130 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74046438 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70959661 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64092057 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.63910265 |
| 9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62371614 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56057578 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48812146 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47654761 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.39947611 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.29451477 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27745844 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25100338 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23448103 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.15243136 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10818922 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07991760 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07483024 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.05000958 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 12.1706805 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94073785 |
| 25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92726740 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91612339 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.90935846 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88662407 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.85765072 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82570939 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77915671 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77070627 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74683475 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71768487 |
| 35 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70600110 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69258100 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65834531 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62949869 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61897260 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61210761 |
| 41 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.60490104 |
| 42 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.59371203 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.58923650 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56510535 |
| 45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55262481 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54951764 |
| 47 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53945495 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52858295 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50889399 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.50191252 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49516428 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48631557 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48151898 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48138899 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45443048 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44176128 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.42333403 |
| 58 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42255581 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41279755 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39673232 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39103980 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37782879 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37781764 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37063940 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34292298 |
| 66 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31359807 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30033246 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29234385 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28043404 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27302855 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27192571 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.26621322 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25032895 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23105982 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22335080 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.21322659 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19977687 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19790552 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19526157 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17468690 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16209558 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12801802 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12801802 |
| 84 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12540504 |
| 85 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12540504 |
| 86 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12540504 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11577415 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11537276 |
| 89 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.11106682 |
| 90 | MYB_26560356_Chip-Seq_TH1_Human | 1.09782614 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09781305 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09276371 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06169538 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05477222 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05133437 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04533183 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03595120 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02274926 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00482537 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00322343 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99691203 |
| 102 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.99529227 |
| 103 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98836273 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98803285 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97941732 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97600001 |
| 107 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.95391679 |
| 108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94258110 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93440789 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93026564 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91609591 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90871497 |
| 113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90554953 |
| 114 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89937808 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89869979 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89746896 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89668592 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87869169 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85674968 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85337543 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85157198 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84348796 |
| 123 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84112370 |
| 124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84018648 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83256612 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82967657 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82860641 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81086618 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79457831 |
| 130 | MAF_26560356_Chip-Seq_TH2_Human | 0.78961031 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77180565 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77034251 |
| 133 | * LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75643566 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75360390 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74902092 |
| 136 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74748644 |
| 137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73188321 |
| 138 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73031614 |
| 139 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.71342295 |
| 140 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.70783941 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.70720769 |
| 142 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69911520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.13715838 |
| 2 | * MP0003724_increased_susceptibility_to | 4.20005251 |
| 3 | MP0006054_spinal_hemorrhage | 3.63031492 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.15855600 |
| 5 | MP0008004_abnormal_stomach_pH | 2.89376700 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.70331003 |
| 7 | MP0009278_abnormal_bone_marrow | 2.70273775 |
| 8 | MP0003303_peritoneal_inflammation | 2.63691387 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.53111511 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.52561337 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.50776760 |
| 12 | * MP0001851_eye_inflammation | 2.41860370 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.38608599 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.37176910 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 2.36129782 |
| 16 | MP0003436_decreased_susceptibility_to | 2.27724398 |
| 17 | MP0002419_abnormal_innate_immunity | 2.09084800 |
| 18 | MP0000685_abnormal_immune_system | 2.08588062 |
| 19 | MP0005083_abnormal_biliary_tract | 2.07759007 |
| 20 | * MP0005025_abnormal_response_to | 2.07660863 |
| 21 | MP0000767_abnormal_smooth_muscle | 2.00138865 |
| 22 | MP0000230_abnormal_systemic_arterial | 1.95369657 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.89943885 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.89943885 |
| 25 | MP0009785_altered_susceptibility_to | 1.87632207 |
| 26 | MP0001790_abnormal_immune_system | 1.85392659 |
| 27 | MP0005387_immune_system_phenotype | 1.85392659 |
| 28 | MP0003075_altered_response_to | 1.81897023 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.81145438 |
| 30 | MP0000343_altered_response_to | 1.80790657 |
| 31 | MP0004272_abnormal_basement_membrane | 1.78005938 |
| 32 | * MP0001533_abnormal_skeleton_physiology | 1.77896790 |
| 33 | * MP0002148_abnormal_hypersensitivity_rea | 1.75183279 |
| 34 | MP0003828_pulmonary_edema | 1.73886515 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.71190273 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.70258762 |
| 37 | MP0000249_abnormal_blood_vessel | 1.69768826 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.66837395 |
| 39 | MP0004947_skin_inflammation | 1.61358163 |
| 40 | MP0004510_myositis | 1.59730402 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.59403859 |
| 42 | * MP0005000_abnormal_immune_tolerance | 1.57040192 |
| 43 | MP0003638_abnormal_response/metabolism_ | 1.56869458 |
| 44 | MP0003279_aneurysm | 1.55694294 |
| 45 | * MP0001800_abnormal_humoral_immune | 1.54982766 |
| 46 | MP0001873_stomach_inflammation | 1.54801517 |
| 47 | * MP0002452_abnormal_antigen_presenting | 1.49112307 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.46147080 |
| 49 | MP0001915_intracranial_hemorrhage | 1.45653320 |
| 50 | MP0004130_abnormal_muscle_cell | 1.45485535 |
| 51 | MP0002405_respiratory_system_inflammati | 1.44604029 |
| 52 | MP0002736_abnormal_nociception_after | 1.40820421 |
| 53 | * MP0002420_abnormal_adaptive_immunity | 1.40751937 |
| 54 | MP0002933_joint_inflammation | 1.39700743 |
| 55 | * MP0001819_abnormal_immune_cell | 1.38337151 |
| 56 | MP0005670_abnormal_white_adipose | 1.35756103 |
| 57 | MP0005023_abnormal_wound_healing | 1.35444954 |
| 58 | * MP0002723_abnormal_immune_serum | 1.35114300 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.32915606 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.31533340 |
| 61 | MP0002132_abnormal_respiratory_system | 1.30100129 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.30051566 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.28166576 |
| 64 | * MP0000689_abnormal_spleen_morphology | 1.25637470 |
| 65 | MP0005409_darkened_coat_color | 1.23563662 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.19851984 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.19486924 |
| 68 | MP0002398_abnormal_bone_marrow | 1.18752197 |
| 69 | MP0005410_abnormal_fertilization | 1.18277886 |
| 70 | MP0003448_altered_tumor_morphology | 1.17995570 |
| 71 | MP0000716_abnormal_immune_system | 1.17489188 |
| 72 | MP0003943_abnormal_hepatobiliary_system | 1.15126804 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.13375617 |
| 74 | * MP0005390_skeleton_phenotype | 1.13207572 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.13178069 |
| 76 | MP0009697_abnormal_copulation | 1.13100532 |
| 77 | MP0008469_abnormal_protein_level | 1.12993292 |
| 78 | MP0009840_abnormal_foam_cell | 1.12381785 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 1.12342737 |
| 80 | MP0004484_altered_response_of | 1.11698789 |
| 81 | MP0002722_abnormal_immune_system | 1.10687738 |
| 82 | MP0009763_increased_sensitivity_to | 1.10292179 |
| 83 | MP0002429_abnormal_blood_cell | 1.09878113 |
| 84 | * MP0001614_abnormal_blood_vessel | 1.06688619 |
| 85 | MP0001853_heart_inflammation | 1.05047605 |
| 86 | MP0008872_abnormal_physiological_respon | 1.04281069 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 1.03835138 |
| 88 | MP0008874_decreased_physiological_sensi | 1.01641410 |
| 89 | MP0002733_abnormal_thermal_nociception | 1.00828527 |
| 90 | MP0000858_altered_metastatic_potential | 0.99824887 |
| 91 | MP0005166_decreased_susceptibility_to | 0.99212039 |
| 92 | MP0003091_abnormal_cell_migration | 0.99081661 |
| 93 | MP0001664_abnormal_digestion | 0.96140641 |
| 94 | * MP0002128_abnormal_blood_circulation | 0.95283565 |
| 95 | MP0002254_reproductive_system_inflammat | 0.94704810 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.92998907 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.92961822 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.92249713 |
| 99 | MP0004147_increased_porphyrin_level | 0.90463202 |
| 100 | MP0006138_congestive_heart_failure | 0.86864778 |
| 101 | MP0001544_abnormal_cardiovascular_syste | 0.86455305 |
| 102 | MP0005385_cardiovascular_system_phenoty | 0.86455305 |
| 103 | MP0009764_decreased_sensitivity_to | 0.84931226 |
| 104 | MP0005164_abnormal_response_to | 0.84302881 |
| 105 | MP0005535_abnormal_body_temperature | 0.83918709 |
| 106 | MP0001968_abnormal_touch/_nociception | 0.83342505 |
| 107 | MP0005165_increased_susceptibility_to | 0.83229378 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.82151690 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.82101142 |
| 110 | MP0002006_tumorigenesis | 0.82002154 |
| 111 | MP0003879_abnormal_hair_cell | 0.81773897 |
| 112 | * MP0009642_abnormal_blood_homeostasis | 0.81014628 |
| 113 | MP0004883_abnormal_blood_vessel | 0.80744554 |
| 114 | MP0002925_abnormal_cardiovascular_devel | 0.79871057 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.79862635 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.78349298 |
| 117 | * MP0000598_abnormal_liver_morphology | 0.77934833 |
| 118 | MP0002972_abnormal_cardiac_muscle | 0.77544508 |
| 119 | MP0001849_ear_inflammation | 0.77154623 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.77139108 |
| 121 | MP0001663_abnormal_digestive_system | 0.76122387 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.76051565 |
| 123 | MP0005671_abnormal_response_to | 0.75729779 |
| 124 | MP0001958_emphysema | 0.73564207 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.71518459 |
| 126 | MP0003866_abnormal_defecation | 0.67899802 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.67319242 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.67117235 |
| 129 | MP0005595_abnormal_vascular_smooth | 0.65912326 |
| 130 | MP0008873_increased_physiological_sensi | 0.65755019 |
| 131 | MP0000609_abnormal_liver_physiology | 0.65082794 |
| 132 | MP0005623_abnormal_meninges_morphology | 0.63494950 |
| 133 | MP0009931_abnormal_skin_appearance | 0.63389424 |
| 134 | MP0000490_abnormal_crypts_of | 0.62072169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.91491015 |
| 2 | Spontaneous hematomas (HP:0007420) | 5.07208057 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 5.06332493 |
| 4 | Prolonged bleeding time (HP:0003010) | 5.01650534 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 4.81945378 |
| 6 | Menorrhagia (HP:0000132) | 4.81788912 |
| 7 | Abnormality of complement system (HP:0005339) | 4.35303545 |
| 8 | Glomerulonephritis (HP:0000099) | 4.33635036 |
| 9 | Joint hemorrhage (HP:0005261) | 4.26244903 |
| 10 | Complement deficiency (HP:0004431) | 4.13536480 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.10458916 |
| 12 | Poikilocytosis (HP:0004447) | 4.03890428 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.99767983 |
| 14 | Spondylolisthesis (HP:0003302) | 3.85013438 |
| 15 | Nasal polyposis (HP:0100582) | 3.77468148 |
| 16 | Epistaxis (HP:0000421) | 3.70626422 |
| 17 | Hematochezia (HP:0002573) | 3.59555993 |
| 18 | Dyschromatopsia (HP:0007641) | 3.53705568 |
| 19 | Acanthocytosis (HP:0001927) | 3.51891250 |
| 20 | Esophageal varix (HP:0002040) | 3.40658459 |
| 21 | Peritonitis (HP:0002586) | 3.38111046 |
| 22 | Cervical subluxation (HP:0003308) | 3.27752418 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.24304916 |
| 24 | Broad metatarsal (HP:0001783) | 3.20957130 |
| 25 | Myositis (HP:0100614) | 3.19659165 |
| 26 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.19330343 |
| 27 | Shallow orbits (HP:0000586) | 3.13682083 |
| 28 | Impaired platelet aggregation (HP:0003540) | 3.13605675 |
| 29 | Abnormal platelet function (HP:0011869) | 3.13605675 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13604065 |
| 31 | Thrombocytosis (HP:0001894) | 3.09244773 |
| 32 | Nonimmune hydrops fetalis (HP:0001790) | 3.05972801 |
| 33 | Abnormal pupillary function (HP:0007686) | 3.04819874 |
| 34 | Recurrent abscess formation (HP:0002722) | 3.02744886 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98268822 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.91429601 |
| 37 | Nephritis (HP:0000123) | 2.89204787 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 2.83756092 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81428210 |
| 40 | Increased density of long bones (HP:0006392) | 2.79960181 |
| 41 | Stomatitis (HP:0010280) | 2.79571177 |
| 42 | Short nail (HP:0001799) | 2.79556626 |
| 43 | Cellulitis (HP:0100658) | 2.77961386 |
| 44 | Polygenic inheritance (HP:0010982) | 2.75445536 |
| 45 | Thoracic kyphosis (HP:0002942) | 2.71220836 |
| 46 | Enlarged penis (HP:0000040) | 2.70379458 |
| 47 | IgM deficiency (HP:0002850) | 2.70256977 |
| 48 | Polycythemia (HP:0001901) | 2.70019744 |
| 49 | Loss of speech (HP:0002371) | 2.69249189 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69177586 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.69177586 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.68815260 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.64423838 |
| 54 | Purpura (HP:0000979) | 2.63678596 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.60221907 |
| 56 | Paralysis (HP:0003470) | 2.55213462 |
| 57 | Beaking of vertebral bodies (HP:0004568) | 2.55051990 |
| 58 | Pustule (HP:0200039) | 2.54351441 |
| 59 | Chronic otitis media (HP:0000389) | 2.53383159 |
| 60 | Abnormality of the lumbar spine (HP:0100712) | 2.53146207 |
| 61 | Joint stiffness (HP:0001387) | 2.52077863 |
| 62 | Deformed sella turcica (HP:0002681) | 2.51593018 |
| 63 | Wrist flexion contracture (HP:0001239) | 2.51477826 |
| 64 | Recurrent bacterial skin infections (HP:0005406) | 2.51260140 |
| 65 | Orchitis (HP:0100796) | 2.51150255 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49955074 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49955074 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49955074 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.48890813 |
| 70 | Abnormality of lateral ventricle (HP:0030047) | 2.47681178 |
| 71 | Abnormal platelet volume (HP:0011876) | 2.46100611 |
| 72 | Spontaneous abortion (HP:0005268) | 2.44030710 |
| 73 | Joint swelling (HP:0001386) | 2.43331683 |
| 74 | Obstructive lung disease (HP:0006536) | 2.41576127 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41576127 |
| 76 | Arterial tortuosity (HP:0005116) | 2.40882000 |
| 77 | Bruising susceptibility (HP:0000978) | 2.39557340 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.37699269 |
| 79 | Increased mean platelet volume (HP:0011877) | 2.36571420 |
| 80 | Pulmonary embolism (HP:0002204) | 2.35396369 |
| 81 | Vascular tortuosity (HP:0004948) | 2.33587658 |
| 82 | Abnormality of the peritoneum (HP:0002585) | 2.30100126 |
| 83 | Portal hypertension (HP:0001409) | 2.29487328 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 2.29415501 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.27716322 |
| 86 | Colitis (HP:0002583) | 2.26421423 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.25845883 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24490530 |
| 89 | Aortic aneurysm (HP:0004942) | 2.23928865 |
| 90 | Gingival bleeding (HP:0000225) | 2.23319999 |
| 91 | Abnormality of the sella turcica (HP:0002679) | 2.23301822 |
| 92 | Tinnitus (HP:0000360) | 2.23195105 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.22944531 |
| 94 | Abnormality of the thoracic spine (HP:0100711) | 2.19701387 |
| 95 | Toxemia of pregnancy (HP:0100603) | 2.18037491 |
| 96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.17512563 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.15497362 |
| 98 | Facial diplegia (HP:0001349) | 2.15308268 |
| 99 | Chest pain (HP:0100749) | 2.14704231 |
| 100 | Petechiae (HP:0000967) | 2.11628042 |
| 101 | Protrusio acetabuli (HP:0003179) | 2.11505597 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.09126068 |
| 103 | Decreased central vision (HP:0007663) | 2.08062354 |
| 104 | Arterial thrombosis (HP:0004420) | 2.07665555 |
| 105 | Abnormality of the hepatic vasculature (HP:0006707) | 2.06760587 |
| 106 | J-shaped sella turcica (HP:0002680) | 2.06079944 |
| 107 | Aortic dissection (HP:0002647) | 2.04853503 |
| 108 | Conjunctival telangiectasia (HP:0000524) | 2.04759783 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03692926 |
| 110 | Increased IgM level (HP:0003496) | 2.03539600 |
| 111 | Radial bowing (HP:0002986) | 2.03297530 |
| 112 | Abnormal auditory evoked potentials (HP:0006958) | 2.03250125 |
| 113 | Inflammation of the large intestine (HP:0002037) | 2.02535503 |
| 114 | Bronchomalacia (HP:0002780) | 2.00913196 |
| 115 | Periodontitis (HP:0000704) | 2.00333101 |
| 116 | Aneurysm (HP:0002617) | 1.99103704 |
| 117 | Encephalitis (HP:0002383) | 1.98683744 |
| 118 | 11 pairs of ribs (HP:0000878) | 1.97249053 |
| 119 | Hyperthyroidism (HP:0000836) | 1.92787113 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 1.91939014 |
| 121 | Broad face (HP:0000283) | 1.91729171 |
| 122 | Flat acetabular roof (HP:0003180) | 1.87313773 |
| 123 | Vertigo (HP:0002321) | 1.86829086 |
| 124 | Amyloidosis (HP:0011034) | 1.86523809 |
| 125 | Thrombophlebitis (HP:0004418) | 1.85550372 |
| 126 | Multifactorial inheritance (HP:0001426) | 1.84756786 |
| 127 | Thickened calvaria (HP:0002684) | 1.84595348 |
| 128 | Abnormality of the pericardium (HP:0001697) | 1.84317107 |
| 129 | Episodic fever (HP:0001954) | 1.79405475 |
| 130 | Upper limb muscle weakness (HP:0003484) | 1.70991954 |
| 131 | Xanthomatosis (HP:0000991) | 1.68918580 |
| 132 | Papillary thyroid carcinoma (HP:0002895) | 1.68264489 |
| 133 | Basal ganglia calcification (HP:0002135) | 1.66845562 |
| 134 | Increased serum ferritin (HP:0003281) | 1.65197126 |
| 135 | Leukocytosis (HP:0001974) | 1.64607614 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.63257313 |
| 137 | Amaurosis fugax (HP:0100576) | 1.62330280 |
| 138 | Nausea (HP:0002018) | 1.60176957 |
| 139 | Distal lower limb amyotrophy (HP:0008944) | 1.59917384 |
| 140 | Cerebral ischemia (HP:0002637) | 1.59704799 |
| 141 | Muscle fiber splitting (HP:0003555) | 1.58520980 |
| 142 | Panhypogammaglobulinemia (HP:0003139) | 1.57453972 |
| 143 | Muscle fibrillation (HP:0010546) | 1.56918749 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.56237973 |
| 145 | Male infertility (HP:0003251) | 1.53648304 |
| 146 | Abnormality of binocular vision (HP:0011514) | 1.53237749 |
| 147 | Diplopia (HP:0000651) | 1.53237749 |
| 148 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.51578891 |
| 149 | Thyroid-stimulating hormone excess (HP:0002925) | 1.51303945 |
| 150 | Mucosal telangiectasiae (HP:0100579) | 1.50696013 |
| 151 | Vasculitis (HP:0002633) | 1.48526483 |
| 152 | Testicular neoplasm (HP:0010788) | 1.47389205 |
| 153 | Tongue fasciculations (HP:0001308) | 1.47222752 |
| 154 | Dysautonomia (HP:0002459) | 1.45021377 |
| 155 | Myocardial infarction (HP:0001658) | 1.44674000 |
| 156 | Microcytic anemia (HP:0001935) | 1.43731271 |
| 157 | Arthralgia (HP:0002829) | 1.42045089 |
| 158 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.38667326 |
| 159 | Meningitis (HP:0001287) | 1.30447177 |
| 160 | Granulocytopenia (HP:0001913) | 1.30275883 |
| 161 | Autoimmune thrombocytopenia (HP:0001973) | 1.29061000 |
| 162 | Recurrent viral infections (HP:0004429) | 1.28234124 |
| 163 | Eosinophilia (HP:0001880) | 1.28091173 |
| 164 | Exertional dyspnea (HP:0002875) | 1.25904711 |
| 165 | Hypertriglyceridemia (HP:0002155) | 1.25820196 |
| 166 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.25658938 |
| 167 | Recurrent fungal infections (HP:0002841) | 1.22142858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.39547940 |
| 2 | KDR | 4.93770364 |
| 3 | TGFBR2 | 3.56952019 |
| 4 | ERN1 | 3.55676652 |
| 5 | MST4 | 3.35029931 |
| 6 | RIPK1 | 3.31512162 |
| 7 | MST1R | 3.10446323 |
| 8 | TGFBR1 | 3.03079272 |
| 9 | EIF2AK1 | 2.42502286 |
| 10 | MAP4K1 | 2.30014413 |
| 11 | PIK3CG | 2.26494700 |
| 12 | EPHB1 | 2.24056245 |
| 13 | TAOK3 | 2.11798201 |
| 14 | TRIB3 | 2.03446390 |
| 15 | PKN2 | 1.97964378 |
| 16 | MUSK | 1.92869902 |
| 17 | EEF2K | 1.91074730 |
| 18 | BMPR2 | 1.76591624 |
| 19 | JAK3 | 1.69500178 |
| 20 | CAMK1D | 1.62574433 |
| 21 | BLK | 1.55477730 |
| 22 | TBK1 | 1.49942802 |
| 23 | EPHA3 | 1.49217982 |
| 24 | MAP2K3 | 1.49123220 |
| 25 | FES | 1.48543390 |
| 26 | ITK | 1.44910098 |
| 27 | FGR | 1.39235225 |
| 28 | MAP3K3 | 1.30573538 |
| 29 | STK3 | 1.29594914 |
| 30 | KIT | 1.27956804 |
| 31 | ADRBK2 | 1.27351881 |
| 32 | TEC | 1.23884117 |
| 33 | PTK6 | 1.19878657 |
| 34 | IKBKE | 1.19475924 |
| 35 | MAP3K14 | 1.18800941 |
| 36 | BTK | 1.11802611 |
| 37 | CSK | 1.06575977 |
| 38 | IRAK1 | 1.05957544 |
| 39 | MAPKAPK5 | 1.05413104 |
| 40 | JAK1 | 1.04061220 |
| 41 | DAPK2 | 1.02790777 |
| 42 | PRKCH | 1.02104920 |
| 43 | PIM2 | 0.98843633 |
| 44 | MET | 0.98716209 |
| 45 | MAP3K6 | 0.98170215 |
| 46 | DAPK3 | 0.97694605 |
| 47 | MAPKAPK3 | 0.96679409 |
| 48 | MAPK12 | 0.94225484 |
| 49 | CAMK1G | 0.93660529 |
| 50 | BMX | 0.93588453 |
| 51 | PAK1 | 0.93193160 |
| 52 | FGFR4 | 0.92583698 |
| 53 | SIK3 | 0.91897787 |
| 54 | TYK2 | 0.89824582 |
| 55 | JAK2 | 0.89398338 |
| 56 | HCK | 0.88000886 |
| 57 | MAP3K11 | 0.87814513 |
| 58 | IKBKB | 0.87400947 |
| 59 | LRRK2 | 0.87388480 |
| 60 | ZAP70 | 0.85261896 |
| 61 | ADRBK1 | 0.85126981 |
| 62 | LMTK2 | 0.84712253 |
| 63 | CDK9 | 0.82349364 |
| 64 | CDK8 | 0.82331118 |
| 65 | EPHB2 | 0.79740260 |
| 66 | MATK | 0.78047710 |
| 67 | CAMKK2 | 0.77135354 |
| 68 | STK10 | 0.76723428 |
| 69 | MAP3K5 | 0.76527991 |
| 70 | STK24 | 0.76422458 |
| 71 | STK4 | 0.74143912 |
| 72 | PTK2B | 0.72476445 |
| 73 | PRKG2 | 0.72189524 |
| 74 | ACVR1B | 0.72059703 |
| 75 | MARK3 | 0.71605938 |
| 76 | RPS6KA4 | 0.70626389 |
| 77 | NLK | 0.69973999 |
| 78 | TNIK | 0.69958548 |
| 79 | TESK2 | 0.66384863 |
| 80 | TRPM7 | 0.66047969 |
| 81 | PRKD1 | 0.65370680 |
| 82 | FGFR3 | 0.64481866 |
| 83 | LCK | 0.64060418 |
| 84 | CAMK4 | 0.63744754 |
| 85 | MAP3K1 | 0.62336124 |
| 86 | PDGFRB | 0.61218634 |
| 87 | PIM1 | 0.61213355 |
| 88 | TXK | 0.60151479 |
| 89 | IRAK4 | 0.58605150 |
| 90 | PRKD2 | 0.58153937 |
| 91 | IGF1R | 0.57768277 |
| 92 | TTN | 0.57704218 |
| 93 | MAPK4 | 0.56465354 |
| 94 | PLK2 | 0.54965927 |
| 95 | PDPK1 | 0.54176035 |
| 96 | NUAK1 | 0.53980413 |
| 97 | GRK1 | 0.53875257 |
| 98 | PRKACG | 0.52005397 |
| 99 | ERBB2 | 0.51968577 |
| 100 | TAOK2 | 0.50843602 |
| 101 | LYN | 0.50569901 |
| 102 | YES1 | 0.50041860 |
| 103 | MOS | 0.49075578 |
| 104 | TAOK1 | 0.49048551 |
| 105 | FYN | 0.48533632 |
| 106 | INSRR | 0.48186267 |
| 107 | EGFR | 0.46436774 |
| 108 | CHUK | 0.46105437 |
| 109 | SYK | 0.45833504 |
| 110 | PRKCQ | 0.44835846 |
| 111 | MAP2K1 | 0.44230879 |
| 112 | MAPK7 | 0.43672579 |
| 113 | PDK1 | 0.42716138 |
| 114 | PKN1 | 0.39606382 |
| 115 | PRKG1 | 0.39106464 |
| 116 | RET | 0.38780178 |
| 117 | RPS6KA6 | 0.38428748 |
| 118 | RPS6KB2 | 0.37782021 |
| 119 | PLK4 | 0.37479022 |
| 120 | MYLK | 0.37398131 |
| 121 | TNK2 | 0.37137994 |
| 122 | PRKCD | 0.35744735 |
| 123 | PAK4 | 0.35470853 |
| 124 | RPS6KA2 | 0.35225212 |
| 125 | MAP3K7 | 0.34888677 |
| 126 | IRAK2 | 0.34642967 |
| 127 | FLT3 | 0.33987639 |
| 128 | ARAF | 0.32897755 |
| 129 | PRKAA2 | 0.32585252 |
| 130 | BCKDK | 0.32018333 |
| 131 | CSF1R | 0.31824578 |
| 132 | SGK2 | 0.31557460 |
| 133 | TLK1 | 0.31228262 |
| 134 | GRK6 | 0.29545878 |
| 135 | HIPK2 | 0.29186062 |
| 136 | MAPKAPK2 | 0.29030390 |
| 137 | RAF1 | 0.28976704 |
| 138 | GRK5 | 0.28914787 |
| 139 | RIPK4 | 0.28805370 |
| 140 | FER | 0.28340294 |
| 141 | ILK | 0.27938468 |
| 142 | SRC | 0.27828137 |
| 143 | PTK2 | 0.27507273 |
| 144 | ABL1 | 0.27159206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.13361997 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.26281263 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.91980130 |
| 4 | * Malaria_Homo sapiens_hsa05144 | 3.29820351 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.58666447 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.54431317 |
| 7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.51107087 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46234572 |
| 9 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.26883310 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23228601 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.91875783 |
| 12 | Platelet activation_Homo sapiens_hsa04611 | 1.86588620 |
| 13 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.79823161 |
| 14 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.79343546 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72392545 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.63311874 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.61787217 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61192430 |
| 19 | Gap junction_Homo sapiens_hsa04540 | 1.60862591 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59310160 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46787302 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.44896049 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.43095798 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.36860316 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32253700 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.30706439 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30131958 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.26407155 |
| 29 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24585635 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.22690517 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18298520 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.18187438 |
| 33 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17746192 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15435592 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13894863 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13825762 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.13256510 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12251762 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11149206 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10716541 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10212132 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08414586 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07155687 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 1.04924415 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.04872814 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04765253 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04413198 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03997561 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 1.03747055 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03558638 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02777851 |
| 52 | Measles_Homo sapiens_hsa05162 | 1.01512793 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01483633 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.01157396 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99705193 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98525233 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97359136 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97250152 |
| 59 | Alcoholism_Homo sapiens_hsa05034 | 0.96234210 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94121640 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93736687 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.92676800 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92256525 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91426515 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.90866161 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90853769 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88025085 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86788469 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86033096 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85494668 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85270630 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85137211 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83056068 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82650177 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81311200 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.80653687 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79940672 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.79600568 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79390818 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.78298728 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76887110 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.76053551 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.75378039 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.75135413 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.73760421 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72890471 |
| 87 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72827786 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71069521 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.70092699 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69241395 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.69228017 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68828055 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68251270 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66982369 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65991847 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63571754 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63540382 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63260286 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62409344 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61847233 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61572620 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.61410895 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61104912 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60688347 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60683215 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60079761 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58615621 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58079224 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57999657 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57997583 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57632769 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57623911 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57573024 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54920769 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53912745 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52314188 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51523733 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50989406 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50507076 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50343955 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50198131 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.49480581 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49300628 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48469244 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.47457673 |
| 126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47407970 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46603527 |
| 128 | Morphine addiction_Homo sapiens_hsa05032 | 0.46324388 |
| 129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45796024 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44438586 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43950955 |
| 132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43455880 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43391419 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41092054 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41008100 |
| 136 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40805240 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.37624286 |
| 138 | Ribosome_Homo sapiens_hsa03010 | 0.35895145 |
| 139 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35796875 |
| 140 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34134445 |
| 141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32604435 |
| 142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32581813 |
| 143 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32296350 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29644208 |
| 145 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24787628 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23914316 |

